Cointime

Home / Vivo Capital / investments

Vivo Capital

company

Investments

Number of Investments
Number of Lead Investments
16
4
Vivo Capital has made 16 investments. Their most recent investment was on Nov 29, 2022, when Rgenta Therapeutics, Inc raised
Date Company Name Round Money Raised Industry Lead Investor
Nov 29, 2022 Rgenta Therapeutics Series A — Biotechnology —
Oct 27, 2022 Neocis Series D — Dental —
Jul 6, 2022 Tebra Series B — Electronic Health Record (EHR) —
May 25, 2021 Rgenta Therapeutics Seed — Biotechnology —
May 6, 2021 Aerobiotix Series Unknown — Health Care Yes
Jan 5, 2021 Terns Pharmaceuticals Series C — Biotechnology —
Oct 8, 2020 Neocis Series D — Dental —
Sep 4, 2019 Passage Bio Series B — Biotechnology —
Feb 15, 2019 Passage Bio Series A — Biotechnology —
Oct 30, 2018 Terns Pharmaceuticals Series B — Biotechnology Yes
Nov 27, 2017 Medeor Therapeutics Series B — Biotechnology —
Aug 3, 2017 Amyris Post-IPO Equity — Biotechnology Yes
Apr 13, 2016 Kala Pharmaceuticals Series C — Biotechnology —
Nov 6, 2013 Ocera Therapeutics Post-IPO Equity — Biopharma —
Apr 15, 2011 Eiger BioPharmaceuticals Series A — Biotechnology —
Feb 25, 2009 Eiger BioPharmaceuticals Series A — Biotechnology Yes
Cointime
เนื้อหา
บริษัท